1. Issues with Current Drug DiscoveryA ProposalArch2POCMA Drug Development Approachfrom Disease Targets to their Clinical Validation Stephen FriendSage Bionetworks (a non-profit…

1. Arch2POCMA Drug Development Approachfrom Disease Targets to their Clinical Validation Stephen FriendSage Bionetworks (a non-profit foundation) IBC San FranciscoAug 3,…

1. Use of Bionetworks to build maps of disease: Moving beyond the linearIntegrating layers of omics data modelsand use of compute spaces Stephen Friend MD PhDSage Bionetworks…

1. it is more about how we do science than whatadvantages of an open innovation compute spacefor building better models of diseasebeyond siloed drug discovery- Arch2POCM…

1. Why not use data intensive science to build better models of diseases together?– beyond current rewards   Stephen  H  Friend  MD  PhD   Sage  Bionetworks  (non-­‐profit)…

Shifting Paradigms: Knowledge Powered Audience Engagement Ying Li Chief Data Scientist, Parllay Ying Li Chief Data Scientist, Parllay Data Science and Computational Advertising…

1. Friday, April 23, 2010 2. Moving from Narrative to Designwith Open Source and Open Data Jeff HammerbacherChief Scientist and Vice President of Products, ClouderaApril…

Slide 1Sage Congress 2012 Session 1: Synapse Michael Kellen, PhD Director of Technology, Sage Bionetworks SYNAPSE SHARED COLLABORATION SPACE GITHUB Slide 2 “If I have seen…

GENOME ANALYTICS SOFTWARE-ENABLING FRACTAL APPROACH TO A GLOBAL, GENOME-BASED ECONOMY, WITH PERSONALIZED HEALTH-CARE SYSTEMS Featuring the DNA / RNA System as a Fractal Genomic…